ClinVar Miner

Submissions for variant NM_033360.4(KRAS):c.64C>G (p.Gln22Glu)

dbSNP: rs121913236
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Invitae RCV000654936 SCV000776842 pathogenic RASopathy 2021-06-17 criteria provided, single submitter clinical testing For these reasons, this variant has been classified as Pathogenic. Experimental studies have shown that this missense change disrupts the normal function of KRAS (PMID: 24803665, 20949621). This variant has been reported to be de novo with confirmed paternity in an individual affected with Noonan syndrome (PMID: 17056636) and has also been reported in an individual with cardio-facial-cutaneous syndrome or possibly Noonan syndrome (PMID: 17324647). This variant is not present in population databases (ExAC no frequency). This sequence change replaces glutamine with glutamic acid at codon 22 of the KRAS protein (p.Gln22Glu). The glutamine residue is highly conserved and there is a small physicochemical difference between glutamine and glutamic acid.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.